[NFS-01-1]The role of TDP-43 in the lipid dysregulation in CNS of ALS
Naohiro Egawa1,2,3(1.Department of Neurology, Kyoto University Graduate School of Medicine, Japan, 2.iPSC-Based Drug Discovery and Development Team, RIKEN BioResource Research Center, Japan, 3.Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan)

Profile: Dr. Egawa has been engaged in (reverse) translational research of neurological diseases (ALS, dementia with Lewy bodies, Alzheimer's disease and sleep-related diseases) using stem cell models, rodent models and clinical informatics.
7/2019 - : Instructor, Kyoto University Hospital
4/2018 - : Visiting Researcher, RIKEN
4/2018 - : Visiting Researcher, CiRA, Kyoto University
6/2016 - : Assistant Professor, Department of Neurology, Kyoto University Graduate School of Medicine
4/2015 - 5/2016: Research Fellow, Massachusetts General Hospital,
Harvard Medical School
4/2010 - 3/2015: Research Fellow, Center for iPS Cell Research and Application (CiRA),
Kyoto University
4/2006 - 3/2010: Ph.D. in Medicine, Kyoto University
3/2001: M.D. Kyoto University
Password required to view
Abstract password authentication.
You can find the password on page 13 of the program book.
You can find the password on page 13 of the program book.
